Inovio Pharmaceuticals Inc.

(INO) Trade

By |
Inovio Pharmaceuticals Inc.

Profile

Inovio is taking immunotherapy to the next level in the fight against cancer and infectious diseases. We are the only immunotherapy company that has reported generating T cells in vivo in high quantity that are fully functional and whose killing capacity correlates with relevant clinical outcomes with a favorable safety profile. With an expanding portfolio of immune therapies, the company is advancing a growing preclinical and clinical stage product pipeline. Partners and collaborators include MedImmune, Regeneron Pharmaceuticals, Genentech, GeneOne Life Science, Plumbline Life Sciences, ApolloBio Corporation, The Wistar Institute, Laval University, University of Pennsylvania, Drexel University, DARPA, NIH, HIV Vaccines Trial Network, National Cancer Institute, and U.S. Military HIV Research Program. For more information, visit www.inovio.com.

Contact Information

Website: www.inovio.com
Email: investor.relations@inovio.com
Main Phone: +1 267 440-4200
Address: 660 West Germantown Pike
Address 2: Suite 110
State: PA
City / Town: Plymouth Meeting
Country: USA
Postal Code: 19462

Issuer Information

Exchange: NGS
CEO: J. Joseph Kim
Employees: 106
Issuer Type: CS - Common Stock
Sector/Industry: Cyclical
NAICS: Biological Produ
$ 4.40 $ 0.12 (2.80%)
Last Price 4.40 Change $ 0.12 Change % 2.80 Tick N/A
Bid 4.36 Bid Size 5,000.00 Ask 4.55 Ask Size 200.00
Open 4.29 High 4.41 Low 4.21 Prev Close 4.28
Last Trade Volume 1.4 mi 52 Wk Hi 9.86 52 Wk Low 4.20
Market Cap 397.3 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 90,296,164.00 EPS (TTM) -1.21 PE Ratio N/A Exchange NGS
  Last 3 Mo Last 12 Mo
Number of Insider Trades 4 38
Number of Buys 2 29
Number of Sells 2 9
Net Activity -100866 504662
Last 10 Buys Shares
Morton C. Collins 1,000
Morton C. Collins 1,000
Morton C. Collins 1,000
Morton C. Collins 1,000
Morton C. Collins 1,000
Morton C. Collins 1,000
Niranjan Sardesai 1,000
Simon X. Benito 1,000
Angel Cabrera 1,000
Peter D. Kies 1,000
Last 10 Sell Shares
Simon X. Benito 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 31 31 31 31
Low Target Price Estimate 13 13 13 13
Mean Target Price Estimate 18.6 18.6 18.6 18.6
Standard Deviation 7.23 7.23 7.23 7.23
Date of Most Recent Estimate 08/09/16 07/17/16 07/17/16 08/19/16
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 4 5 5 5
Moderate Buy 0 0 0 0
Hold 1 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.4 1 1 1